BIVDA have submitted our response to NHSE and NICE’s recent consultation on their proposals for an integrated, rules-based medtech pathway. We broadly welcome the pathway’s potential to assist with the adoption of innovation in the NHS. However, we have come concerns regarding delivery. There is also wariness among industry that NHSE will place unrealistic demands on developers. Successful, realistic delivery…
Ben KempAugust 20, 2024